• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种抗肿瘤药物莱达克林及其他抗肿瘤1-硝基-9-氨基吖啶对HeLa s3细胞的DNA损伤

DNA damage in HeLa s3 cells by an antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.

作者信息

Woynarowski J M, Bartoszek A, Konopa J

出版信息

Chem Biol Interact. 1984 May;49(3):311-28. doi: 10.1016/0009-2797(84)90105-4.

DOI:10.1016/0009-2797(84)90105-4
PMID:6722943
Abstract

Ledakrin and seven other antitumor and cytotoxic derivatives of 1-nitro-9-aminoacridine were shown to induce DNA-single strand breaks in HeLa S3 cells as found by alkaline sucrose gradient centrifugation. The induced DNA damage is of non-random character. Some of Ledakrin -induced DNA breaks are probably generated by endonucleolytic cleavage in the course of repair processes as indicated by experiments with Novobiocin, an antibiotic preventing the incision step of DNA repair. Other Ledakrin -induced DNA breaks observed on alkaline sucrose gradients may arise from alkali-labile sites in DNA. Most of such sites seem to be converted to breaks after brief exposure to alkali. The extent of DNA damage by 1-nitro-9-aminoacridines was found to be correlated with cytotoxic activities of these compounds against HeLa S3 cells. Furthermore, Ledakrin and other derivatives seem to induce DNA-repair synthesis in HeLa S3 cells as judged by the stimulation of hydroxyurea (HU)-resistant incorporation of [3H] thymidine into DNA. The agents studied differ in their concentrations required to produce a considerable stimulation of DNA repair, whereas the maximal level of this effect is similar for all the derivatives assayed. The former values are correlated with cytotoxic activities of these compounds and seem to reflect the overall extent of DNA damage by 1-nitro-9-aminoacridines. Stimulation of DNA-repair synthesis is gradually shut off during prolonged incubation of the cells with Ledakrin or during postincubation of the cells in a drug-free medium. Such postincubation results also in the gradual accumulation of DNA-single strand breaks as observed by alkaline sucrose centrifugation. Hence, HeLa S3 cells are incapable of efficiently removing DNA damage by 1-nitro-9-aminoacridines, though the drug's action activates temporarily some repair mechanisms. The reported results suggest that overall DNA damage may contribute to the cytotoxic effects of 1-nitro-9-aminoacridines besides previously found ability of these agents to form interstrand DNA cross-links.

摘要

通过碱性蔗糖梯度离心法发现,利达克林及1-硝基-9-氨基吖啶的其他七种抗肿瘤和细胞毒性衍生物可诱导HeLa S3细胞中的DNA单链断裂。诱导产生的DNA损伤具有非随机性质。如新霉素(一种可阻止DNA修复切口步骤的抗生素)实验所示,利达克林诱导产生的一些DNA断裂可能是在修复过程中由核酸内切酶切割产生的。在碱性蔗糖梯度上观察到的其他利达克林诱导的DNA断裂可能源于DNA中的碱不稳定位点。大多数此类位点在短暂暴露于碱后似乎会转化为断裂。已发现1-硝基-9-氨基吖啶对DNA的损伤程度与这些化合物对HeLa S3细胞 的细胞毒性活性相关。此外,根据对[3H]胸腺嘧啶核苷抗羟基脲(HU)掺入DNA的刺激作用判断,利达克林和其他衍生物似乎可诱导HeLa S3细胞中的DNA修复合成。所研究的这些试剂在产生对DNA修复的显著刺激所需的浓度上有所不同,而对于所有检测的衍生物,这种效应的最大水平相似。前者的值与这些化合物的细胞毒性活性相关,似乎反映了1-硝基-9-氨基吖啶对DNA的总体损伤程度。在用利达克林长时间孵育细胞的过程中或在无药物培养基中对细胞进行孵育后,DNA修复合成的刺激作用会逐渐停止。这种孵育后结果还会导致如碱性蔗糖离心法所观察到的DNA单链断裂逐渐积累。因此,HeLa S3细胞无法有效去除1-硝基-9-氨基吖啶造成的DNA损伤,尽管该药物的作用会暂时激活一些修复机制。报告的结果表明,除了先前发现的这些试剂形成链间DNA交联的能力外,总体DNA损伤可能也会导致1-硝基-9-氨基吖啶的细胞毒性作用。

相似文献

1
DNA damage in HeLa s3 cells by an antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.一种抗肿瘤药物莱达克林及其他抗肿瘤1-硝基-9-氨基吖啶对HeLa s3细胞的DNA损伤
Chem Biol Interact. 1984 May;49(3):311-28. doi: 10.1016/0009-2797(84)90105-4.
2
The mechanism of inhibition of DNA replication in HeLa S3 cells by the antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.抗肿瘤药物莱达克林及其他抗肿瘤1-硝基-9-氨基吖啶对HeLa S3细胞DNA复制的抑制机制
Biochim Biophys Acta. 1985 Jun 24;825(2):244-53. doi: 10.1016/0167-4781(85)90109-5.
3
Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells.抗肿瘤1-硝基-9-氨基吖啶诱导L1210白血病细胞中DNA-蛋白质交联
Biochem Pharmacol. 1989 Nov 15;38(22):4095-101. doi: 10.1016/0006-2952(89)90691-6.
4
Effects of ledakrin on DNA and cell cycle in HeLa S3 cells.来达克林对HeLa S3细胞DNA和细胞周期的影响。
Drugs Exp Clin Res. 1986;12(6-7):517-21.
5
32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.用32P后标记分析法研究抗肿瘤药物硝吖啶(雷得菌素)及其他硝基吖啶在不同生物系统中形成DNA加合物的情况。
Biochem Pharmacol. 1989 Apr 15;38(8):1301-12. doi: 10.1016/0006-2952(89)90337-7.
6
The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.细胞毒性和抗肿瘤1-硝基吖啶的作用模式。II. 1-硝基吖啶衍生物(雷达克林或硝吖啶)在体内通过酶介导与哺乳动物或细菌细胞的DNA及其他大分子的共价结合
Chem Biol Interact. 1983 Feb;43(2):151-73. doi: 10.1016/0009-2797(83)90093-5.
7
32P-post-labelling analysis of DNA adducts formed by antitumor 1-nitro-9-aminoacridines with DNA of HeLa S3 cells.用32P后标记分析法研究抗肿瘤1-硝基-9-氨基吖啶与HeLa S3细胞DNA形成的DNA加合物
Biochem Pharmacol. 1987 Dec 1;36(23):4169-71. doi: 10.1016/0006-2952(87)90577-6.
8
DNA damage and cytotoxicity of nitracrine in cultured HeLa cells.硝吖啶对培养的HeLa细胞的DNA损伤和细胞毒性。
Biochim Biophys Acta. 1989 Aug 14;1008(3):339-45. doi: 10.1016/0167-4781(89)90025-0.
9
The mode of action of cytotoxic and antitumor 1-nitroacridines. III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridines.细胞毒性和抗肿瘤1-硝基吖啶的作用方式。III. 1-硝基吖啶对哺乳动物或细菌细胞DNA的体内链间交联作用。
Chem Biol Interact. 1983 Feb;43(2):175-97. doi: 10.1016/0009-2797(83)90094-7.
10
Intercalation model for DNA-cross linking in a 1-nitro-9-aminoacridine derivative, an analog of the antitumor agent "ledakrin" (nitracrine).一种1-硝基-9-氨基吖啶衍生物(抗肿瘤药物“利达克林”(硝吖啶)的类似物)中DNA交联的嵌入模型。
J Biomol Struct Dyn. 1984 Dec;2(3):511-24. doi: 10.1080/07391102.1984.10507588.

引用本文的文献

1
New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.旧药新希望:重新审视作为抗癌药物的 DNA 结合小分子。
Future Oncol. 2009 Dec;5(10):1685-704. doi: 10.2217/fon.09.127.